Literature DB >> 17034572

Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.

B-N Pham1, M Martinot-Peignoux, M-P Ripault, N Boyer, V Levy, P Marcellin.   

Abstract

Mixed cryoglobulinaemia is associated strikingly with HCV infection. The aim of this study was to assess whether the adherence to proper methods of collecting samples for cryoglobulin detection was critical or not on virological parameters in hepatitis C virus (HCV) patients. We studied 56 consecutive patients. Blood samples were collected using a conventional method and a blood collection method at 37 degrees C adapted to cryoglobulin detection. HCV core antigen and HCV RNA were measured in sera and cryoglobulins issued from both blood collection methods. In cryoglobulin-positive patients, serum concentrations of HCV core antigen, but not that of HCV RNA, were significantly higher when a conventional method was used, compared to a blood collection method at 37 degrees C (P = 0.001). In the cryoprecipitates, concentration of HCV core antigen was optimum when the blood collection method at 37 degrees C, rather than the conventional method, was applied for cryoglobulin detection (P < 10(-4)). The recovery of HCV core antigen in the cryoprecipitate was improved when cryoglobulins were isolated using the blood collection method at 37 degrees C rather than the conventional method (P < 0.001). HCV parameter measurements and cryoglobulin study should not be performed on the same serum samples due to the potential impact of blood collection methods on results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034572      PMCID: PMC1942051          DOI: 10.1111/j.1365-2249.2006.03196.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.

Authors:  Alessandro R Zanetti; Luisa Romanò; Maurizia Brunetto; Massimo Colombo; Giorgio Bellati; Charles Tackney
Journal:  J Med Virol       Date:  2003-05       Impact factor: 2.327

2.  Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice.

Authors:  D K. Christodoulou; G N. Dalekos; M H. Merkouropoulos; K G. Kistis; G Georgitsi; E Zervou; K Zachou; E V. Tsianos
Journal:  Eur J Intern Med       Date:  2001-09       Impact factor: 4.487

3.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

4.  Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis.

Authors:  Zeid Kayali; Victor E Buckwold; Bridget Zimmerman; Warren N Schmidt
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

5.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

6.  Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.

Authors:  M Hijikata; Y K Shimizu; H Kato; A Iwamoto; J W Shih; H J Alter; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

Authors:  Magali Bouvier-Alias; Keyur Patel; Harel Dahari; Stéphanie Beaucourt; Patrick Larderie; Lawrence Blatt; Christophe Hezode; Gaston Picchio; Daniel Dhumeaux; Avidan U Neumann; John G McHutchison; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

8.  Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.

Authors:  V S Wong; W Egner; T Elsey; D Brown; G J Alexander
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

9.  Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection.

Authors:  S H Choo; H S So; J M Cho; W S Ryu
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

10.  Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.

Authors:  K N Ward; W Dhaliwal; K L Ashworth; E J Clutterbuck; C G Teo
Journal:  J Med Virol       Date:  1994-08       Impact factor: 2.327

View more
  1 in total

1.  Device for carrying blood samples at 37°C for cryoglobulin test.

Authors:  Moon H Nahm; W Winn Chatham; William H Benjamin
Journal:  Clin Vaccine Immunol       Date:  2012-07-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.